Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 5 | $38,750,000 |
Sells | 6 | $1,602,356 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Oct 2023 16:23 | RVLP | RVL Pharmaceuticals plc | HARSAUL FOUNDATION | 10% | 20 Oct 2023 | Sale | 4,758,899 | 0.0312 | 148,478 | I |
23 Oct 2023 16:23 | RVLP | RVL Pharmaceuticals plc | HARSAUL FOUNDATION | 10% | 19 Oct 2023 | Sale | 9,363,760 | 0.0461 | 431,669 | I |
23 Oct 2023 13:06 | RVLP | RVL Pharmaceuticals plc | ALTCHEM LTD | 10% | 20 Oct 2023 | Sale | 4,758,899 | 0.0312 | 148,478 | D |
23 Oct 2023 13:06 | RVLP | RVL Pharmaceuticals plc | ALTCHEM LTD | 10% | 19 Oct 2023 | Sale | 9,363,760 | 0.0461 | 431,669 | D |
20 Oct 2023 15:59 | RVLP | RVL Pharmaceuticals plc | HARSAUL FOUNDATION | 10% | 18 Oct 2023 | Sale | 3,421,537 | 0.0646 | 221,031 | I |
20 Oct 2023 13:36 | RVLP | RVL Pharmaceuticals plc | ALTCHEM LTD | 10% | 18 Oct 2023 | Sale | 3,421,537 | 0.0646 | 221,031 | D |
09 Aug 2022 17:23 | RVLP | RVL Pharmaceuticals plc | SCHAUB JAMES | EVP and COO | 08 Aug 2022 | Purchase | 150,000 | 1.55 | 232,500 | D |
09 Aug 2022 17:22 | RVLP | RVL Pharmaceuticals plc | MARKISON BRIAN A | Chief Executive Officer | 08 Aug 2022 | Purchase | 850,000 | 1.55 | 1,317,500 | D |
09 Aug 2022 17:21 | RVLP | RVL Pharmaceuticals plc | BURGSTAHLER DAVID F | Director , 10% | 08 Aug 2022 | Purchase | 8,000,000 | 1.55 | 12,400,000 | I |
09 Aug 2022 17:19 | RVLP | RVL Pharmaceuticals plc | VENKATARAMAN SRIRAM | Director , 10% | 08 Aug 2022 | Purchase | 8,000,000 | 1.55 | 12,400,000 | I |
09 Aug 2022 17:18 | RVLP | RVL Pharmaceuticals plc | AVISTA HEALTHCARE PARTNERS, L.P. | 10% | 08 Aug 2022 | Purchase | 8,000,000 | 1.55 | 12,400,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)